Burton Paul Frederick 4

What Happened
Burton Paul Frederick, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was granted an award of 2,854 derivative shares on June 30, 2026. The filing lists a per-share value of $2.19, for a total reported value of roughly $6,250. This was an equity award/derivative acquisition (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-02 (Form 4 accession 0002006956-26-000003).
• Amount: 2,854 shares; Reported price/value: $2.19 per share; Total value: ~$6,250.
• Type: Derivative award/grant (Form 4 transaction code A).
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes/conditions: None disclosed in the provided data (no 10b5-1, tax withholding, or cashless sale noted).
• Filing timeliness: No late filing flag indicated in the supplied information.

Context
This was an equity award (likely restricted stock units or similar derivative award) issued to a director. Such grants are common as compensation and do not necessarily signal buying or selling intent by the insider. Derivative awards may vest over time or convert to common shares per the company’s equity plan—check the company’s proxy or Form 8-K for plan terms if you want vesting or convertibility details.